Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection

Candidate human immunodeficiency virus type 1 (HIV-1) vaccines designed to elicit T-cell immunity in HIV-1-uninfected persons are under investigation in phase I to III clinical trials. Little is known about how these vaccines impact the immunologic response postinfection in persons who break through...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Horton, Helen, Havenar-Daughton, Colin, Lee, Deborah, Moore, Erin, Cao, Jianhong, McNevin, John, Andrus, Thomas, Zhu, Haiying, Rubin, Abbe, Zhu, Tuofu, Celum, Connie, McElrath, M. Juliana
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2006
נושאים:
Vaccines and Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1617262/
https://ncbi.nlm.nih.gov/pubmed/16973582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00794-06
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים